SUMOylation of SETD8, which we have demonstrated to be modulated by PIAS1 and SENP6, stabilizes SETD8 and further enhances its binding with MYC via SUMO‐SIM interaction, leading to increased MYC methylation and tumor progression. Here, KMT5A is linked to neoplasm.